Have a personal or library account? Click to login
An Evaluation of Serum Procalcitonin and C-Reactive Protein Levels as Diagnostic and Prognostic Biomarkers of Severe Sepsis Cover

An Evaluation of Serum Procalcitonin and C-Reactive Protein Levels as Diagnostic and Prognostic Biomarkers of Severe Sepsis

The Journal of Critical Care Medicine
Volume 1 (2015): Issue 4 (October 2015)
By: Janos Szederjesi,  Emoke Almasy,  Alexandra Lazar,  Adina Huțanu,  Iudita Badea and  Anca Georgescu  
Open Access
|Nov 2015

References

  1. 1. Angus DC, Linde-Zwirble WT, Lidicker J, et al. Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001;29:1303-10.10.1097/00003246-200107000-0000211445675
    Search in Google Scholar
  2. 2. Dellinger RP. Cardiovascular management of septic shock. Crit Care Med. 2003;31:946-55.10.1097/01.CCM.0000057403.73299.A612627010
    Search in Google Scholar
  3. 3. Bone R, Balk R, Cerra F, et al. Definitions for sepsisand organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of ChestPhysicians / Society of Critical Care Medicine”. Chest. 1992;101: 1644-55.10.1378/chest.101.6.16441303622
    Search in Google Scholar
  4. 4. Linde-Zwirble WT, Angus DC. Severe sepsis epidemiology: Sampling, selection, and society. Crit Care. 2004;8:222-6.10.1186/cc291752285915312201
    Search in Google Scholar
  5. 5. Hervald H, Egesten A. Sepsis. Pro-Inflammatory and Anti- Inflammatory Responses. Controb Microbiol. Basel, Krager, 2011, vol 17, pp 1-11.10.1159/isbn.978-3-8055-9711-1
    Search in Google Scholar
  6. 6. Dellinger RP, Levy MM, Rhodes A, et al. Surviving Sepsis Campaign: International guidelines for management of severe sepsisand septic shock: 2012. Crit Care Med. 2013;41:580-637.10.1097/CCM.0b013e31827e83af23353941
    Search in Google Scholar
  7. 7. Giamarellos-Bourboulis EJ, Giannopoulou P, Grecka P, et al. Should procalcitonin be introduced in the diagnostic criteria for the systemic inflammatory response syndrome and sepsis? J Crit Care. 2004; 19:152-7.
    Search in Google Scholar
  8. 8. James D. Faix. Biomarkers of sepsis. Crit Rev Clin Lab Sci. 2013;50:23-36.10.3109/10408363.2013.764490361396223480440
    Search in Google Scholar
  9. 9. Szederjesi J, Almasy E, Lazar A, Huțanu A, Georgescu A. The Role of Angiopoietine-2 in the Diagnosis and Prognosis of Sepsis. J Crit Care Med. 2015;1:18-23.10.1515/jccm-2015-0004595328029967811
    Search in Google Scholar
  10. 10. Schröder J, Staubach KH, Zabel P, Stüber F, Kremer B. Procalcitonin as a marker of severity in septic shock. Langenbecks Arch Surg. 1999;384:33-8.10.1007/s00423005017010367627
    Search in Google Scholar
  11. 11. Enguix-Armada A, Escobar-Conesa R, La Torre AG, De La Torre- Prados MV. Usefulness of several biomarkers in the management of septic patients: C-reactive protein, procalcitonin, presepsin and mid-regional pro-adrenomedullin. Clin Chem Lab Med. 2015 17. pii: /j/cclm.ahead-of-print/cclm-2015-0243/cclm-2015-0243.xml. doi: 10.1515/cclm-2015-0243. [Epub ahead of print]10.1515/cclm-2015-024326083268
    Search in Google Scholar
  12. 12. Samraj RS, Zingarelli B, Wong HR. Role of biomarkers in sepsis care. Shock. 2013;40:358-65.10.1097/SHK.0b013e3182a66bd6380604724088989
    Search in Google Scholar
  13. 13. Levy MM, Fink MP, Marshall JC, et al; SCCM/ESICM/ACCP/ ATS/ SIS: 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med. 2003; 31:1250-6.10.1097/01.CCM.0000050454.01978.3B12682500
    Search in Google Scholar
  14. 14. Vincent JL, Sakr Y, Sprung CL, et al. Sepsis in European intensive care units: results of the SOAP study. Crit Care Med. 2006;34:344-53.10.1097/01.CCM.0000194725.48928.3A
    Search in Google Scholar
  15. 15. Nargis W, Ibrahim Md, Adamed BU. Procalcitonin versus C-reactive protein: Usefulness as biomarker of sepsis in ICU patient. Int J Crit Illn Inj Sci. 2014;4:195-9.10.4103/2229-5151.141356420054425337480
    Search in Google Scholar
  16. 16. Koenig SM, Truwit JD. Ventilator-Associated Pneumonia: diagnosis, treatment, and prevention. Clin Microbiol Rev. 2006;19:637-57.10.1128/CMR.00051-05159269417041138
    Search in Google Scholar
  17. 17. Magill SS, Dumyati G, Ray SM, Fridkin SK. Evaluating Epidemiology and Improving Surveillance of Infections Associated with Health Care, United States. Emerg Infect Dis. 2015;21:1537-42.10.3201/eid2109.150508455013726291035
    Search in Google Scholar
  18. 18. Que YA, Guessous I, Dupuis-Lozeron E, et al. Prognostication of Mortality in Critically Ill Patients With Severe Infections. Chest. 2015;148:674-82.10.1378/chest.15-012326065577
    Search in Google Scholar
  19. 19. Enguix-Armada A, Escobar-Conesa R, La Torre AG et al. Usefulness of several biomarkers in the management of septic patients: C-reactive protein, procalcitonin, presepsin and midregional pro-adrenomedullin. Clin Chem Lab Med. 2015. pii:/j/cclm.ahead-of-print/cclm-2015-0243/cclm-2015-0243.xml. doi: 10.1515/cclm-2015-0243. [Epub ahead of print].10.1515/cclm-2015-024326083268
    Search in Google Scholar
  20. 20. Brun-Buisson C, Doyon F, Carlet J, et al. Incidence, Risk Factors, and Outcome of Severe Sepsis and Septic Shock in Adults. A Multicenter {rospective Study in Intensive Care Units. JAMA. 1995;274:968-74.10.1001/jama.1995.03530120060042
    Search in Google Scholar
  21. 21. Hinriksdóttir G, Tryggvadóttir Á, Ólafsdóttir AS, et al. Fatness but Not Fitness Relative to the Fat-Free Mass Is Related to C-Reactive Protein in 18 Year-Old Adolescents. PLoS One. 2015;10:e0130597. doi: 10.1371/journal.pone.0130597. eCollection 2015.10.1371/journal.pone.0130597446806726075745
    Search in Google Scholar
  22. 22. Parrett AL, Valentine RJ, Arngrímsson SA et al. Adiposity, activity, fitness, and C-reactive protein in children. Med Sci Sports Exerc. 2010;42:1981-6.10.1249/MSS.0b013e3181e0355e20386340
    Search in Google Scholar
  23. 23. Waheeda Nargis, Md Ibrahim, Borhan Uddin Ahamed. Procalcitonin versus C-reactive protein: Usefulness as biomarker of sepsis in ICU patient. Int J Crit. 2014;4:195-9.10.4103/2229-5151.141356420054425337480
    Search in Google Scholar
  24. 24. Akcay I, Okoh AK, Yalav O, et al. The prognostic value of procalcitonin, CRP and thyroid hormones in secondary peritonitis: a single-center prospective study. Ulus Travma Acil Cerrahi Derg. 2014;20:343-352. 10.5505/tjtes.2014.9835425541846
    Search in Google Scholar
DOI: https://doi.org/10.1515/jccm-2015-0022 | Journal eISSN: 2393-1817 | Journal ISSN: 2393-1809
Journal RSS Feed
Language: English
Page range: 147 - 153
Submitted on: Jul 16, 2015
Accepted on: Sep 1, 2015
Published on: Nov 10, 2015
Published by: University of Medicine, Pharmacy, Science and Technology of Targu Mures
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
severe sepsis,
procalcitonin,
C-reactive protein,
prognostic biomarkers
Related subjects:
Medicine,
Clinical medicine,
Anaesthesiology,
Emergency medicine and intensive-care medicine,
Internal medicine,
Internal medicine, other,
Surgery,
Surgery, other

© 2015 Janos Szederjesi, Emoke Almasy, Alexandra Lazar, Adina Huțanu, Iudita Badea, Anca Georgescu, published by University of Medicine, Pharmacy, Science and Technology of Targu Mures
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous articleVolume 1 (2015): Issue 4 (October 2015)Next article